Aptevo Therapeutics Stock Forward View - Price Action Indicator
| APVO Stock | USD 7.39 0.45 5.74% |
Aptevo Stock outlook is based on your current time horizon. Although Aptevo Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Aptevo Therapeutics' systematic risk associated with finding meaningful patterns of Aptevo Therapeutics fundamentals over time.
The RSI of Aptevo Therapeutics' share price is below 30 as of today. This suggests that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Aptevo Therapeutics, making its price go up or down. Momentum 28
Sell Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (1.90) | EPS Estimate Current Year (96.84) | EPS Estimate Next Year (28.80) | Wall Street Target Price 377.9997 | EPS Estimate Current Quarter (2.09) |
Using Aptevo Therapeutics hype-based prediction, you can estimate the value of Aptevo Therapeutics from the perspective of Aptevo Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Aptevo Therapeutics after-hype prediction price | USD 7.39 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Aptevo Therapeutics to cross-verify your projections. Aptevo Therapeutics Additional Predictive Modules
Most predictive techniques to examine Aptevo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aptevo using various technical indicators. When you analyze Aptevo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| 0.045 | (0.23) |
| Check Aptevo Therapeutics Volatility | Backtest Aptevo Therapeutics | Information Ratio |
Aptevo Therapeutics Trading Date Momentum
| On January 30 2026 Aptevo Therapeutics was traded for 7.39 at the closing time. The top price for the day was 7.39 and the lowest listed price was 7.39 . There was no trading activity during the period 0.0. Lack of trading volume on January 30, 2026 did not affect price variability. The overall trading delta against the current closing price is 6.09% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Aptevo Therapeutics to competition |
Other Forecasting Options for Aptevo Therapeutics
For every potential investor in Aptevo, whether a beginner or expert, Aptevo Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Aptevo Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Aptevo. Basic forecasting techniques help filter out the noise by identifying Aptevo Therapeutics' price trends.Aptevo Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aptevo Therapeutics stock to make a market-neutral strategy. Peer analysis of Aptevo Therapeutics could also be used in its relative valuation, which is a method of valuing Aptevo Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Aptevo Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Aptevo Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aptevo Therapeutics shares will generate the highest return on investment. By undertsting and applying Aptevo Therapeutics stock market strength indicators, traders can identify Aptevo Therapeutics entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.94 | |||
| Day Median Price | 7.39 | |||
| Day Typical Price | 7.39 | |||
| Price Action Indicator | (0.23) | |||
| Period Momentum Indicator | (0.45) | |||
| Relative Strength Index | 28.13 |
Aptevo Therapeutics Risk Indicators
The analysis of Aptevo Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Aptevo Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting aptevo stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.51 | |||
| Standard Deviation | 6.55 | |||
| Variance | 42.92 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Aptevo Therapeutics
The number of cover stories for Aptevo Therapeutics depends on current market conditions and Aptevo Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aptevo Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aptevo Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Aptevo Therapeutics Short Properties
Aptevo Therapeutics' future price predictability will typically decrease when Aptevo Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Aptevo Therapeutics often depends not only on the future outlook of the potential Aptevo Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aptevo Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 767.05 | |
| Cash And Short Term Investments | 8.7 M |
Check out Historical Fundamental Analysis of Aptevo Therapeutics to cross-verify your projections. To learn how to invest in Aptevo Stock, please use our How to Invest in Aptevo Therapeutics guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Will Biotechnology sector continue expanding? Could Aptevo diversify its offerings? Factors like these will boost the valuation of Aptevo Therapeutics. If investors know Aptevo will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Aptevo Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Aptevo Therapeutics requires distinguishing between market price and book value, where the latter reflects Aptevo's accounting equity. The concept of intrinsic value—what Aptevo Therapeutics' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Aptevo Therapeutics' price substantially above or below its fundamental value.
Understanding that Aptevo Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aptevo Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Aptevo Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.